{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:08:15Z","timestamp":1791497295514,"version":"4.3.4"},"reference-count":130,"publisher":"Elsevier BV","issue":"12","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.it.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T21:21:38Z","timestamp":1375737698000},"page":"592-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":326,"title":["B cell receptor signaling in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"34","author":[{"given":"Jan A.","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2013.07.002_bib0005","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/28.8.7003001","article-title":"Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas","volume":"28","author":"Stein","year":"1980","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.it.2013.07.002_bib0010","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0015","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"Burkle","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0020","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0025","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-06-1204","article-title":"Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma","volume":"12","author":"Ruan","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.it.2013.07.002_bib0030","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.07.002_bib0040","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nature03724","article-title":"Cellular and genetic mechanisms of self tolerance and autoimmunity","volume":"435","author":"Goodnow","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/asheducation-2011.1.96","article-title":"Nurture versus nature: the microenvironment in chronic lymphocytic leukemia","volume":"2011","author":"Burger","year":"2011","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.it.2013.07.002_bib0055","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0065","doi-asserted-by":"crossref","first-page":"e2012067","DOI":"10.4084\/mjhid.2012.067","article-title":"Novel agents and emerging strategies for targeting the B-cell receptor pathway in CLL","volume":"4","author":"Efremov","year":"2012","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.it.2013.07.002_bib0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cr.2012.152","article-title":"Chronic lymphocytic leukemia: a tale of one or two signals?","volume":"23","author":"Chiorazzi","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.it.2013.07.002_bib0090","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1182\/blood-2012-05-423194","article-title":"Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia","volume":"120","author":"Wiestner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","article-title":"Targeting pathological B cell receptor signalling in lymphoid malignancies","volume":"12","author":"Young","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2013.07.002_bib0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood-2012-09-454439","article-title":"CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL","volume":"121","author":"Binder","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2010.06.006","article-title":"Intrinsic properties of immunoglobulin IgG1 isotype-switched B cell receptors promote microclustering and the initiation of signaling","volume":"32","author":"Liu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.it.2013.07.002_bib0115","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0120","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0125","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0130","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0135","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2010-09-307249","article-title":"CCL3 (MIP-1{alpha}) plasma levels and the risk for disease progression in chronic lymphocytic leukemia (CLL)","volume":"117","author":"Sivina","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","article-title":"Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia","volume":"200","author":"Messmer","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","article-title":"B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor","volume":"21","author":"Chiorazzi","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0155","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0160","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","article-title":"Chronic lymphocytic leukemia: revelations from the B-cell receptor","volume":"103","author":"Stevenson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0165","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0170","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.07.002_bib0175","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities","volume":"117","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0180","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells","volume":"194","author":"Klein","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0896-8411(88)90068-6","article-title":"Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies","volume":"1","author":"Broker","year":"1988","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2013.07.002_bib0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.169.1.255","article-title":"Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia","volume":"169","author":"Sthoeger","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0195","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/leu.2011.311","article-title":"Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59\/IGKV3-20 receptors with rheumatoid factor activity","volume":"26","author":"Kostareli","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0200","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/leu.2012.238","article-title":"A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient","volume":"27","author":"Hoogeboom","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0210","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V76.3.562.562","article-title":"Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies","volume":"76","author":"Borche","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0215","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","article-title":"Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity","volume":"115","author":"Herve","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.07.002_bib0220","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0225","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0230","doi-asserted-by":"crossref","first-page":"e15992","DOI":"10.1371\/journal.pone.0015992","article-title":"Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells","volume":"5","author":"Binder","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.it.2013.07.002_bib0235","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2009-12-254847","article-title":"Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo","volume":"115","author":"Krysov","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0240","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0245","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2004-05-1715","article-title":"ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia","volume":"105","author":"Chen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0250","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.leu.2403726","article-title":"ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype","volume":"19","author":"Nolz","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0255","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/eji.200526355","article-title":"B lymphocytes in humans express ZAP-70 when activated in vivo","volume":"36","author":"Cutrona","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0260","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.leu.2404138","article-title":"ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage","volume":"20","author":"Scielzo","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0265","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0270","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2006-12-062265","article-title":"ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0275","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2006-03-011759","article-title":"ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells","volume":"109","author":"Gobessi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0280","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1182\/blood-2005-04-1718","article-title":"ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Richardson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0285","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2010-04-282400","article-title":"Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib","volume":"117","author":"Messmer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0290","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1182\/blood-2011-01-333682","article-title":"ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1\/2 activation","volume":"118","author":"Calpe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0295","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2010.36","article-title":"CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells","volume":"24","author":"Vaisitti","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0300","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2010-09-307249","article-title":"CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic lymphocytic leukemia","volume":"117","author":"Sivina","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0305","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1182\/blood-2011-03-342436","article-title":"Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia","volume":"118","author":"Yan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0310","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1084\/jem.177.6.1821","article-title":"Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes","volume":"177","author":"Schall","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0315","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.162.8.4455","article-title":"Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells","volume":"162","author":"Krzysiek","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0320","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI40645","article-title":"Comprehensive assessment of chemokine expression profiles by flow cytometry","volume":"120","author":"Eberlein","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.07.002_bib0325","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.it.2013.07.002_bib0335","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel Syk inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0340","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Hoellenriegel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0345","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo","volume":"119","author":"Ponader","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0350","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2011-05-352492","article-title":"The phosphoinositide 3\u2032-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia","volume":"118","author":"Hoellenriegel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0355","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","article-title":"CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival","volume":"69","author":"Zucchetto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2013.07.002_bib0360","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","article-title":"Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22","volume":"32","author":"Ghia","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0365","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni735","article-title":"B cells and professional APCs recruit regulatory T cells via CCL4","volume":"2","author":"Bystry","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0370","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0375","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.it.2013.07.002_bib0380","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","article-title":"Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer","volume":"117","author":"Kraus","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.it.2013.07.002_bib0385","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI200522094","article-title":"Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis","volume":"115","author":"Contri","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2013.07.002_bib0390","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.346","article-title":"Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"23","author":"Gobessi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0395","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","article-title":"Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy","volume":"112","author":"Muzio","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0400","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1182\/blood-2007-11-125278","article-title":"The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target","volume":"111","author":"Hewamana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0405","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pbio.0060152","article-title":"The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas","volume":"6","author":"Refaeli","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2013.07.002_bib0410","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2141.2010.08244.x","article-title":"SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)","volume":"150","author":"Philippen","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.it.2013.07.002_bib0415","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V90.4.1387","article-title":"Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia","volume":"90","author":"Thompson","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0420","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.346","article-title":"Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"23","author":"Gobessi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2013.07.002_bib0425","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood-2012-12-474718","article-title":"Targeting B-cell anergy in chronic lymphocytic leukemia","volume":"121","author":"Apollonio","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20122739","article-title":"Clonal expansion in B-CLL: Fungal drivers or self-service?","volume":"210","author":"Greaves","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0435","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood-2012-09-452805","article-title":"CLL clonal heterogeneity: an ecology of competing subpopulations","volume":"120","author":"Wu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0440","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1146\/annurev-biochem-090308-173656","article-title":"The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling","volume":"80","author":"Dar","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.it.2013.07.002_bib0445","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cbpa.2010.06.168","article-title":"Targeted covalent drugs of the kinase family","volume":"14","author":"Singh","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.it.2013.07.002_bib0450","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0455","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","article-title":"Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies","volume":"31","author":"Advani","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.it.2013.07.002_bib0460","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.immuni.2006.11.012","article-title":"Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing","volume":"26","author":"de Gorter","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.it.2013.07.002_bib0465","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"de Rooij","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0470","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1002\/eji.1830241228","article-title":"Expression of Bruton's tyrosine kinase protein within the B cell lineage","volume":"24","author":"Genevier","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0475","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.8332901","article-title":"Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice","volume":"261","author":"Rawlings","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.it.2013.07.002_bib0480","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0485","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.it.2013.07.002_bib0490","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0495","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.191.10.1745","article-title":"Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement","volume":"191","author":"Petro","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0500","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.20011866","article-title":"The B cell antigen receptor controls integrin activity through Btk and PLCgamma2","volume":"198","author":"Spaargaren","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0505","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/eji.200535799","article-title":"Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing","volume":"36","author":"Ortolano","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0510","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2013.07.002_bib0515","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton's tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0520","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2013.07.002_bib0525","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2012-08-452607","article-title":"Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B cell receptor signaling","volume":"121","author":"Burger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0535","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0540","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.it.2013.07.002_bib0545","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2013.07.002_bib0550","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1128\/MCB.22.24.8580-8591.2002","article-title":"Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex","volume":"22","author":"Jou","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.it.2013.07.002_bib0555","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1073560","article-title":"Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice","volume":"297","author":"Okkenhaug","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.it.2013.07.002_bib0560","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2002-02-0539","article-title":"Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta","volume":"100","author":"Ringshausen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0565","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood-2005-04-1483","article-title":"Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes","volume":"107","author":"Kienle","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0570","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.leukres.2008.03.003","article-title":"Bone marrow fibroblasts induce expression of PI3K\/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells","volume":"32","author":"Edelmann","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.it.2013.07.002_bib0575","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0580","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","article-title":"The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells","volume":"111","author":"Longo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0585","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","article-title":"CAL-101, a p110{delta} selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability","volume":"117","author":"Lannutti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0590","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","article-title":"Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals","volume":"116","author":"Herman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0595","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2009-06-222943","article-title":"PI3K\/p110{delta} is a novel therapeutic target in multiple myeloma","volume":"116","author":"Ikeda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0600","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0605","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/378303a0","article-title":"Syk tyrosine kinase required for mouse viability and B-cell development","volume":"378","author":"Cheng","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2013.07.002_bib0610","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1182\/blood-2008-05-158618","article-title":"Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target","volume":"113","author":"Young","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2013.07.002_bib0615","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.immuni.2007.04.011","article-title":"Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1","volume":"26","author":"Zarbock","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.it.2013.07.002_bib0620","doi-asserted-by":"crossref","first-page":"17263","DOI":"10.1074\/jbc.M000689200","article-title":"Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk","volume":"275","author":"Ganju","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2013.07.002_bib0625","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/art.23992","article-title":"Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial","volume":"58","author":"Weinblatt","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2013.07.002_bib0630","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.it.2013.07.002_bib0635","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2013.07.002_bib0640","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1200\/JCO.2012.43.3748","article-title":"Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia","volume":"30","author":"Cheson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.it.2013.07.002_bib0645","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.devcel.2010.01.009","article-title":"Regulation of developmental lymphangiogenesis by Syk(+) leukocytes","volume":"18","author":"Bohmer","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.it.2013.07.002_bib0650","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-5699(99)01574-1","article-title":"Tyrosine kinase SYK: essential functions for immunoreceptor signalling","volume":"21","author":"Turner","year":"2000","journal-title":"Immunol Today"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490613001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490613001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:02:18Z","timestamp":1688407338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490613001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":130,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1471490613001099"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2013.07.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell receptor signaling in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}